AQP4 and optic neuritis: It has been suggested that antibody testing for AQP4-IgG be reserved to patients with severe visual loss, poor visual recovery, bilateral or sequential visual involvement, recurrent optic neuritis [75] and unique findings on the MRI of the orbits.